2Yan Qian and Jian-Gao Fan Shanghai, China Center for Fatty Liver Disease, First People’ s Hospi- tal , Shanghai Jiaotong University, Shanghai 200080, China.Obesity, fatty liver and liver cancer[J].Hepatobiliary & Pancreatic Diseases International,2005,4(2):173-177. 被引量：11
2Bruix J,Sherman M.Management of hepatocellular carcinomaHepatology,2005. 被引量：7
3Hisaka T;Yano H;Haramaki M.Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation,1999. 被引量：1
4Presta LG;Chen H;Connor SJ;Chisholm V,Meng YG,Krummen L,Winkler M,Ferrara N.Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders,1997. 被引量：1
5Kim KJ Li B;Winer J;Armanini M;Gillett N,Phillips HS,Ferrara N.Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo,1993. 被引量：1
6Autiero M,Luttun A,Tjwa M,et al.Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. Journal of Thrombosis and Haemostasis . 2003 被引量：2
7Llovet JM,Ricci S,Mazzaferro V,Hilgard P,Gane E,Blanc JF,de Oliveira AC,Santoro A,Raoul JL,Forner A,Schwartz M,Porta C,Zeuzem S,Bolondi L,Greten TF,Galle PR,Seitz JF,Borbath I,Haussinger D,Giannaris T,Shan M,Moscovici M,Voliotis D,Bruix J.Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine . 2008 被引量：13
8Folkman J.Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Medicine . 1995 被引量：3
9Thomas MB,Chadha R,Glover K,Wang X,Morris J,Brown T,Rashid A,Dancey J,Abbruzzese JL.Phase2study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer . 2007 被引量：2
10Philip PA,Mahoney MR,Allmer C,Thomas J,Pitot HC,Kim G,Donehower RC,Fitch T,Picus J,Erlichman C.Phase II study of Erlotinib(OSI-774)in patients with advanced hepatocellular cancer. Journal of Clinical Oncology . 2005 被引量：3
5Xiao-Yan Duan, Liang Qiao and Jian-Gao Fan Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China ,Storr Liver Unit at the Westmead Millennium Institute, the University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2012,11(1):18-27. 被引量：16
